雖然這篇Finerenone nejm鄉民發文沒有被收入到精華區:在Finerenone nejm這個話題中,我們另外找到其它相關的精選爆讚文章
[爆卦]Finerenone nejm是什麼?優點缺點精華區懶人包
你可能也想看看
搜尋相關網站
-
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#1Cardiovascular Events with Finerenone in Kidney Disease ...
Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, has favorable effects on cardiorenal outcomes in patients with ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#2Effect of Finerenone on Chronic Kidney Disease Outcomes in ...
The Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD) trial was designed to test the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#3Cardiovascular Events with Finerenone in Kidney Disease ...
n engl j med 385;24 nejm.org December 9, 2021. 2253. Finerenone in Kidney Disease and Diabetes. Chronic kidney disease (CKD) exac-.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#4Finerenone in Kidney Disease and Type 2 Diabetes | NEJM
The mineralocorticoid receptor antagonist finerenone has been shown to improve kidney-related outcomes in patients with relatively advanced ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#5Finerenone and Chronic Kidney Disease Outcomes in Type 2 ...
(Dec. 3 issue) 1 conclude that in patients with chronic kidney disease (CKD) and type 2 diabetes, treatment with finerenone resulted in a lower ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#6Effect of Finerenone on Chronic Kidney Disease Outcomes in ...
n engl j med 383;23 nejm.org December 3, 2020 ... diabetes in a 1:1 ratio to receive finerenone or placebo. Eligible patients had a.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#7Halting Relative Hyperaldosteronism in Chronic Kidney Disease
Finerenone — Halting Relative Hyperaldosteronism in Chronic Kidney Disease. List of authors. Julie R. Ingelfinger, M.D.,; and Clifford J.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#8Effect of Finerenone on Chronic Kidney Disease Outcomes in ...
This content requires an NEJM.org account. Create a free account now. Already have an account? Sign in . Quick Take Free Preview. Effect of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#9Cardiovascular Events with Finerenone in Kidney ... - PubMed
由 B Pitt 著作 · 2021 · 被引用 53 次 — Background: Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, has favorable effects on cardiorenal outcomes in ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#10Finerenone and Cardiovascular Outcomes in Patients With ...
The FIDELIO-DKD trial (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) investigated the effects of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#11Does Finerenone Reduce Risk for Heart Failure Events in ...
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#12NEJM on Twitter: "In patients with chronic kidney disease and ...
In patients with chronic kidney disease and type 2 diabetes, treatment with finerenone resulted in lower risks of CKD progression and cardiovascular events ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#13Finerenone Reduces New-Onset Atrial Fibrillation in Patients ...
In the FIDELIO-DKD (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) trial, finerenone significantly ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#14Bayer receives positive CHMP opinion for finerenone as a ...
Finerenone, a non-steroidal, selective mineralocorticoid receptor (MR) ... in the New England Journal of Medicine (NEJM) in October 2020.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#15Cardiovascular and kidney outcomes with finerenone in ...
AbstractAims. The complementary studies FIDELIO-DKD and FIGARO-DKD in patients with type 2 diabetes and chronic kidney disease (CKD) ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#16Finerenone in Diabetic Nephropathy - NephJC
finerenone ; fidelio; randomized controlled trial; RCT; NEJM; diabetes; diabetic nephropathy; diabetic CKD; kidney failure; hyperkalemia.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#17Finerenone in Reducing Kidney Failure and Disease ...
The FIDELIO-DKD trial showed that finerenone has salutary effects on CV and renal outcomes among patients with T2DM and CKD, who were on a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#18Efficacy and Safety of Finerenone in Subjects With Type 2 ...
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease (FIDELIO-DKD). The safety and scientific validity of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#19ESC 2021 – finerenone's song gets a little sweeter | Evaluate
Now finerenone, which was approved under the brand name Kerendia in July, ... presented today and published simultaneously in the NEJM, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#20Finerenone对肾脏疾病和2型糖尿病患者心血管事件的影响
近日,顶级医学期刊NEJM上发表了一篇研究文章,在这项双盲试验中,研究人员将CKD和2型糖尿病患者随机分配接受Finerenone或安慰剂治疗。
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#21Patients with... - The New England Journal of Medicine
Those who received finerenone had reduced disease progression when compared with those on ... NEJM.ORG. Effect of Finerenone on Chronic Kidney Disease.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#22Finerenone (KERENDIA) Approved for Chronic Kidney ...
With approval on July 9, finerenone (Kerendia) becomes the first ... published in NEJM and presented at ASN Kidney Week during October 2020.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#23Bayer Reports Results of Finerenone in P- III FIGARO-DKD CV
Bayer Reports Results of Finerenone in P- III FIGARO-DKD CV Outcomes Study for Chronic Kidney Disease and Type 2 Diabetes.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#24Design and Baseline Characteristics of the Finerenone in ...
Methods: The Finerenone in Reducing Kidney Failure and Disease ... 16 and the protocol is available with the full text of this article at NEJM.org.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#25Cardiovascular Events with Finerenone in Kidney ... - MashupMD
RT @hswapnil: Hot in the heels of FIDELIO, FIGARO drops at #ESCCongress @NEJM https://t.co/koWk03pDg0 Top line result positive as expecte… - view on twitter.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#26FIDELIO-DKD trial renders Kerendia (finerenone) the FDA ...
Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, ... Source:https://www.nejm.org/doi/full/10.1056/NEJMoa2025845.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#27Diabetic Kidney Disease: The Future Is Now in
A nonsteroidal mineralocorticoid antagonist—finerenone—was highlighted in several major randomized ... https://www.nejm.org/doi/full/10.1056/NEJMoa2110956.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#28FDA approves drug to reduce risk of serious kidney and heart ...
FDA has approved Kerendia (finerenone) tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#29Finerenone (Kerendia®) - Straight Healthcare
FIDELIO-DKD study - Finerenone vs Placebo for CKD Outcomes in Patients with Type 2 DM and Kidney Disease, NEJM (2020) [PubMed abstract].
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#30Finerenone slows CKD progression in diabetes patients, finds ...
Finerenone slows CKD progression in diabetes patients, finds NEJM study. Researchers have found in phase III FIDELIO-DKD trial that an ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#31NEJM This Week — Audio Summaries on Apple Podcasts
NEJM This Week — Audio Summaries The New England Journal of Medicine ... cardiovascular events with finerenone in kidney disease and type 2 diabetes, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#32Kerendia (finerenone) - Prior Authorization/Medical Necessity
July 2021. 2. Bakris, GL, Agarwal R, Anker SD, Effect of Finerenone on Chronic Kidney Disease. Outcomes in Type 2 Diabetes. NEJM ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#33Bayer's Finerenone Significantly Reduces CV Outcomes in ...
The applications were based on positive data from the Phase III FIDELIO-DKD published in the NEJM.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#34and 20-mg tablets| Clinical efficacy - KERENDIA® (finerenone ...
Learn about the FIDELIO-DKD trial, which evaluated KERENDIA in patients with CKD associated with T2D. Please read Prescribing Information.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#35非奈利酮治疗肾脏病合并2型糖尿病 - NEJM医学前沿
非奈利酮治疗肾脏病合并2型糖尿病. Finerenone in Kidney Disease and Type 2 Diabetes. 心脑血管疾病糖尿病| 2021.12.08.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#36新世代MRAのfinerenone、DKDの心血管リスク減/NEJM
2型糖尿病を合併する幅広い重症度の慢性腎臓病(CKD)患者の治療において、非ステロイド型選択的ミネラルコルチコイド受容体拮抗薬finerenoneは ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#37糖尿病肾病新药来袭!NEJM揭示Finerenone治疗 ... - 手机搜狐网
总之,Finerenone治疗CKD和2型糖尿病患者,与安慰剂相比,可显著降低CKD进展和心… ... NEJM揭示Finerenone治疗2型糖尿病慢性肾病患者可改善预后.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#38N Engl J Med - : The AMEDEO Literature Guide
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. Reply. N Engl J Med. 2021;384:e42. PubMed; MOURA-NETO JA, Ronco C
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#39The New England Journal of Medicine - 医学文献検索サービス ...
海外ジャーナルレビュー : 「生活習慣病」 · 小児重度肥満へのGNAS変異・メラノコルチン経路の関与を確認 (2021/10/26) NEJM · CKDのT2D患者へのfinerenoneの有益性を示す: ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#40糖尿病腎病新藥來襲!NEJM揭示Finerenone治療2型糖尿病 ...
Finerenone ,一種選擇性非甾體鹽皮質激素受體拮抗劑,在相關慢性腎病(CKD)和2型糖尿病患者的短期試驗中已經證實可以減少蛋白尿。 然而,其對腎臟和心血管 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#41Finerenone and Chronic Kidney Disease ... - UHB Repository
Full text not available from this repository. Official URL: http://content.nejm.org/. Item Type: Article. Additional Information: This article ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#42New data on finerenone for the protection of patients with chronic ...
See: "Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes." Bertram Pitt et al. NEJM August 28, 2021 DOI: 10.1056/NEJMoa2110956.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#43ESC-update 2015 - Charite
ARTS-HF -> Finerenone ... Green JB et al. NEJM 2015 ... daily oral doses of finerenone with eplerenone in patients who.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#44Finerenone (Kerendia) Gets FDA Nod for Chronic Kidney ...
With approval on July 9, finerenone became the first nonsteroidal mineralocorticoid receptor antagonist approved by the FDA for treatment of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#45Finerenone: A Novel Approach to Chronic Kidney Disease in ...
As discussed in the accompanying NEJM editorial, finerenone is highly selective for the MR receptor, so it doesn't seem to cause ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#46CV Effects Of Finerenone | Audio Digest
JW NEJM Journal Watch Audio General Medicine. logo. CV Effects of Finerenone Allan S. Brett, MD Add rating Oct 13, 2021. 0.00 CREDITS.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#47NEJM发表拜耳重要3期临床结果:DKD进展减缓18% CV风险 ...
研究表明,对于合并慢性肾脏病的2型糖尿病患者,finerenone具有明显的肾脏和心血管益处,与现行标准治疗相比,在中位2.6年的时间中,finerenone将肾病进展减缓了18%。研究 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#48This Week in Cardiology - Index - Medscape
Oct 8 2021 This Week in Cardiology Two NEJM papers on mRNA-related myocarditis, ... Sep 17 2021 This Week in Cardiology Cardiac arrest care, finerenone, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#49An Overview of the FIGARO-DKD Trial Design - American ...
... FIGARO-DKD trial, which evaluated cardiovascular and renal outcomes in patients with type 2 diabetes and CKD treated with finerenone.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#50Finerenone治疗2型糖尿病慢性肾病患者可改善预后 - 新闻
Title: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM. Author: George L. Bakris, M.D.,, Rajiv Agarwal, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#51Cardiovascular Events with Finerenone in Kidney Disease and Type ...
ticle at NEJM.org).10 In the Finerenone in Reduc- ing Kidney Failure and Disease Progression in. Diabetic Kidney Disease (FIDELIO-DKD) trial, fi-.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#52Kidney Disease due to Diabetes
Murray et al NEJM 2013; 369: 5. Screening for DKD ... The Collaborative Study Group, NEJM, 329:1456, 1993 ... phase 2b with finerenone. ARTS-DN.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#53NEJM揭示Finerenone治疗2型糖尿病慢性肾病患者可改善预后
来源:生物探索2型糖尿病是全球慢性肾病(CKD)的主要病因,相关指南中推荐伴有CKD的2型糖尿病患者对高血压和高血糖的控制主要以血管紧张素转换酶(ACE) ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#54Kidney News January 13#1 Page 19
Effect of finerenone on chronic kidney disease outcomes in type 2 ... https://www.nejm.org/doi/full/10.1056/NEJ-Moa2025845 Michelle G.A. Lim, MBChB, MRCP, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#55finerenone in type 2 diabetes and chronic kidney disease (CKD)
FIGARO-DKD investigated the effects of finerenone on CV and renal outcomes ... NEJM August 28, 2021 · Filippatos G et al of the FIGARO-DKD ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#56HHP/HPH COVID-19 Updates Webinar Series - Hawaii Health ...
CANVAS (NEJM 8/2017): CV and renal outcomes ... DAPA-CKD (NEJM 10/2020) ... Hyperkalemia. – Finerenone 2.3%. – Placebo 0.9%. FIDELO-DKD. NEJM.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#57A Journal Club on a New Therapeutic Option to Reduce the ...
9) Seminal renal trials such as RENAAL (Brenner et al, NEJM 2001;345-861-9) and IDNT (Lewis et al ... Of note, finerenone is not yet commercially available.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#58Finerenone – Medicines – SPS - Specialist Pharmacy Service
Sep 21 · Results of PIII FIDELIO-DKD (n=7437) reported in NEJM [16]. Nov 20 · Further new data announced from pre-specified exploratory subgroup ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#59Science News from ESC 2021 - Professional Heart Daily
NEJM : Empagliflozin in Heart Failure with a Preserved Ejection Fraction ... Finerenone in patients with chronic kidney disease and type-2 diabetes
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#60KDIGO 2020 Clinical Practice Guideline for Diabetes ...
Design and baseline characteristics of the finerenone in reducing kidney failure and disease progression in diabetic kidney disease trial.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#61糖尿病腎病新藥來襲!NEJM揭示Finerenone治療2型糖尿病慢性腎病 ...
NEJM 揭示Finerenone治療2型糖尿病慢性腎病患者可改善預後 ... Finerenone,一種選擇性非甾體鹽皮質激素受體拮抗劑,在相關慢性腎病(CKD)和2型糖尿病患者的短期試驗中 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#62Finerenone Cuts Kidney, Heart Risks in CKD and T2D
In the trial, 17.8% of the 2,833 patients on finerenone experienced ... In an accompanying editorial, NEJM associate editor Clifford Rosen, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#63糖尿病 - the New England Journal of Medicine(日本語)
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes · 2021-09-02. 2 型糖尿病に対するエフペグレナチド投与による心血管転帰と腎転帰.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#64Cardiovascular Events with Finerenone in ... - TodayHeadline
NEJM.org uses cookies to improve performance by remembering your session ID when you navigate from page to page. This cookie stores just a
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#65Cardiovascular Events with Finerenone in Kidney ... - Knowledia News
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM. 3 months ago. www.nejm.org. 2 min read. difficult.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#66Diabetes Distilled: Finerenone significantly reduces renal and ...
We await the results of FIGARO-DKD to help answer these questions. Click here for the full FIDELIO-DKD results: https://www.nejm.org/doi/full/ ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#67糖尿病肾病新药来袭!NEJM揭示Finerenone治疗2型糖尿病 ...
NEJM 揭示Finerenone治疗2型糖尿病慢性肾病患者可改善预后 ... Finerenone ,一种选择性非甾体盐皮质激素受体拮抗剂,在相关慢性肾病(CKD)和2型糖尿病 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#68SGLT-2 Inhibitors: A New Era in Managing Diabetic Kidney ...
N Engl J Med 2017; 377(7):644-657. doi:10.1056/ NEJM oa1611925 ... Effect of finerenone on chronic kidney disease outcomes in type 2 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#69NEJM发表Finerenone重要3期临床结果:DKD进展减缓18 ...
拜耳在研疗法finerenone的重要临床试验FIDELIO-DKD结果公布。研究表明,对于合并慢性肾脏病的2型糖尿病患者,finerenone具有明显的肾脏和心血管益处, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#70As SGLT2 Inhibitors Create Increased Market Complexities for ...
... diabetic kidney disease (DKD) pipeline agent from Bayer, finerenone. ... 2 https://www.nejm.org/doi/full/10.1056/NEJMoa2024816.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#71NEJM:Finerenone对肾脏疾病和2型糖尿病患者心血管事件的影响 ...
Finerenone 是一种选择性非甾体盐皮质激素受体拮抗剂,对伴有严重白蛋白尿和2型糖尿病的3或4期慢性肾病(CKD)患者心肾结局具有良好的效应。Finerenone在2型糖尿病和更 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#72Novo medicamento tem bons resultados em pacientes com ...
(2020). Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. New England Journal of Medicine. doi: 10.1056/nejmoa2025845 https://www.nejm ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#73Clinical trial shows experimental drug safely slows ...
“We now have evidence that doctors can safely slow diabetic kidney disease progression and reduce cardiovascular event rates using finerenone, a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#74Halting Relative Hyperaldosteronism in Chronic Kidney Disease
The new england journal of medicine n engl j med nejm.org. 1. Finerenone — Halting Relative Hyperaldosteronism in Chronic Kidney Disease.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#753 dicembre 2020 - This week in The NEJM - Network ...
This week in The Nejm: Covid: la risposta alla domanda "quando avremo il vaccino?", covid e tempesta di citochine, Finerenone e nefropatia, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#76Finerenone may lower risk of chronic kidney disease ...
Treatment with finerenone also lowered the risk of cardiovascular events in patients diagnosed with type ... Click to read the study in NEJM.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#77Finerenone may lower risk of chronic kidney disease progression ...
Finerenone treatment lowered the risk of chronic kidney disease (CKD) progression in patients diagnosed with type 2 ... Click to read the study in NEJM.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#78FIDELIO-DKD çalışmasında, ciddi düzeyde kronik böbrek ...
Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney ... Tam Metin Linki: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2110956.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#79ENDOCRINE JOURNAL CLUB (NOVEMBER 2020) - TMedWeb
... who led a discussion on a hot-off-the-press NEJM article on Finerenone, a non-steroidal mineralocorticoid receptor antagonist.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#80搜索
We performed an IRB‐approved post hoc analysis of the SPRINT trial data, recently made available through the NEJM SPRINT Data Analysis ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#81Bayer's finerenone hits main goal of cardiovascular outcomes ...
FIGARO-DKD is the second trial in finerenone's Phase III development ... of Nephrology's (ASN) conference and also published in the NEJM.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#82ACC 2021 Late Breaking Cardiology Study Results | DAIC
Finerenone May Delay New Onset Of Atrial Fibrillation Or Flutter In Patients With Chronic Kidney Disease And Type 2 Diabetes.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#83Multiple Benefits Of Finerenone- Reduces Renal-Risk Besides
Now, in a study published in NEJM, FIDELIO-DKD trial investigators have shown that finerenone slows CKD progression and reduces ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#84Sep 17, 2021 This Week in Cardiology Podcast - Anghami
... Angiography after Cardiac Arrest without ST-Segment Elevation https://www.nejm.org/doi/full/10.1056/NEJMoa1816897 II - Finerenone - FIDELITY: Finerenone ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#85La finérénone améliore le pronostic rénal et cardiovasculaire ...
La finérénone est un ARM non stéroïdien qui semble avoir moins d'effet sur la pression artérielle et la kaliémie ... NEJM 2019,380:2295-306.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#86拜耳创新疗法finerenone上市申请获CDE受理 - 海思科
公开资料显示,finerenone是一款潜在“first-in-class”非甾体选择性盐皮质激素受体 ... 该研究结果同步发布发表在《新英格兰医学杂志》(NEJM)上。
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#87Current awareness services - SALUS - LibGuides at South ...
NEJM. Biologic therapies for severe asthma ... Finerenone in patients with type 2 diabetes and less severe diabetic kidney disease
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#88今日拜耳创新疗法上市申请获CDE受理
公开资料显示,finerenone是一款潜在“first-in-class”非甾体选择性盐皮质激素受体 ... 该研究结果同步发布发表在《新英格兰医学杂志》(NEJM)上。
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#892021/8/28、腎疾患、2型糖尿病、finerenoneと心血管事象との ...
2021/8/28、腎疾患、2型糖尿病、finerenoneと心血管事象との関係を調べた研究「Cardiovascular ... https://www.nejm.org/doi/10.1056/NEJMoa2110956
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#90糖尿病肾病新药!拜耳首创药物Kerendia(finerenone)获美国 ...
相关数据在美国肾脏病学会(ASN)2020年肾脏周上公布,并于2020年10月发表在《新英格兰医学杂志》(NEJM),详见:Effect of Finerenone on Chronic ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#91Early warning found for chronic kidney disease - ScienceDaily
The rigorous NEJM study is a significant breakthrough in ... Finerenone Improves Outcomes in Patients With Mild-to-Moderate Kidney Disease ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#92糖尿病腎病新藥Kerendia在廣泛患者中具有腎臟和心血管益處
2021年7月,美國食品和藥物管理局(FDA)批准Kerendia(finerenone,非奈 ... 醫學雜誌》(NEJM),詳見:Cardiovascular Events with Finerenone in ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#93A new drug for diabetic nephropathy is about to be approved ...
... of Medicine (NEJM) in October 2020. For details, see: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes .
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#94Stage 3 Kidney Disease: Symptoms, Treatment, Coping, and ...
Kerendia (finerenone) is a prescription medicine that can reduce the risk of sustained GFR decline, end-stage kidney disease, cardiovascular death, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#95What to know about microalbuminuria and diabetic nephropathy
Bakris, G. L., (2020). Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. https://www.nejm.org/doi/full/10.1056/ ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#96【5-16】这一周科学家又研究出了啥? - 知乎专栏
拜耳首创药物finerenone 3期心血管结局研究获得成功,已在中国提交上市 ... 同时发表在《新英格兰医学杂志》(NEJM),详见:Effect of Finerenone on ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#97Spencer Phelps - St. Peter's Health Partners - LinkedIn
Patient Retention Panel - Finerenone Program. Bayer Pharmaceuticals ... New article in NEJM looks at Vaccine… Liked by Spencer Phelps.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#98今日,拜耳創新療法上市申請獲CDE受理 - 人人焦點
據此推測,此次finerenone在中國申報上市的適應症可能爲糖尿病腎病。 ... 該研究結果同步發布發表在《新英格蘭醫學雜誌》(NEJM)上。 截圖來源:NEJM.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?>
finerenone 在 コバにゃんチャンネル Youtube 的最佳貼文
finerenone 在 大象中醫 Youtube 的精選貼文
finerenone 在 大象中醫 Youtube 的最佳貼文